HORIZON 2020 - A targeted approach to treating osteoarthritis

Nanocarriers are tiny substances that can be used to transport other materials, such as drugs, to specific areas of the body. The EU-funded TARGETCARE project plans to use them to treat joint and intervertebral disc diseases - improving patients' mobility and quality of life.

Related topics

Funding Researchers Marie Skłodowska Curie actions Denmark Netherlands United Kingdom Switzerland Israel

date: 22/12/2016

Project: Targeting Cartilage Regeneration in join...

acronym: TargetCaRe

See also: Project details

An individual’s mobility can be seriously impaired by chronic low back pain and osteoarthritis caused by the degeneration of cartilage in intervertebral discs and joints. Osteoarthritis is the most common form of arthritis, affecting millions of people worldwide.